|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-8-17
|
|
pubmed:abstractText |
To construct a fusion protein toxin DT389-hIL-13 which comprises the N-terminal 389 amino acids of diphtheria toxin (DT389) and human interlukin 13 (hIL-13), and to explore its cytotoxicity on U251 glioma cells.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0376-2491
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
17
|
|
pubmed:volume |
84
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1024-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15312540-Brain Neoplasms,
pubmed-meshheading:15312540-Cloning, Molecular,
pubmed-meshheading:15312540-Cytotoxicity, Immunologic,
pubmed-meshheading:15312540-DNA, Recombinant,
pubmed-meshheading:15312540-Diphtheria Toxin,
pubmed-meshheading:15312540-Drug Screening Assays, Antitumor,
pubmed-meshheading:15312540-Drug Stability,
pubmed-meshheading:15312540-Escherichia coli,
pubmed-meshheading:15312540-Glioma,
pubmed-meshheading:15312540-Humans,
pubmed-meshheading:15312540-Immunotoxins,
pubmed-meshheading:15312540-Interleukin-13,
pubmed-meshheading:15312540-Plasmids,
pubmed-meshheading:15312540-Prokaryotic Cells,
pubmed-meshheading:15312540-Recombinant Fusion Proteins,
pubmed-meshheading:15312540-Tumor Cells, Cultured
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
[Construction and expression of the fusion protein DT389-hIL-13 and its cytotoxicity to glioma cell lines].
|
|
pubmed:affiliation |
Department of Neurology, Beijing Friendship Hospital, Capital University of Medical Sciences, Beijing 100050, China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
